Comparison of a Suggested Model of Fibrosis in Human Dermal Fibroblasts by Serum from Systemic Sclerosis Patients with Transforming Growth Factor β Induced in vitro Model
Authors:
Open Access
- 2 October 2022
- journal article
- research article
- Vol. 11 (1) , 31-40
Abstract
Systemic sclerosis (SSc) is a chronic autoimmune disease, featuring fibrosis in multiple organs. The serum from SSc patients contain inflammatory mediators, contributing to SSc pathogenesis and could be used to develop cell culture models. Here, we compared the fibrotic effects of serum samples from SSc patients with TGF beta 1 on human dermal fibroblasts (HDFs). HDF cells were cultured in four different culture media supplementations; 10% SSc serum, 10% healthy human serum, 10% fetal bovine serum or 10% FBS supplemented with 10 ng/Ml human TGF beta. The collagen content in cell layers was measured by spectrophotometric Picro-Sirius red staining. The mRNA expression of alpha-SMA, COL I and III, TGF beta 1, arginase and E-Cadherin genes were determined by real time RT-PCR. TGF-beta 1 levels in cell culture supernatants were measured using ELISA. Cell layer collagen content was significantly increased following TGF-beta 1 treatment, compared with FBS group and SSc serum treatment in comparison with healthy controls. Although not statistically significant, the mRNA expression of alpha-SMA, COLI and III, TGF beta 1, and arginase increased upon TGF-beta 1 treatment in comparison with FBS group, and in SSc serum treatment group in comparison with healthy controls. E-Cadherin decreased following TGF-beta 1 treatment and SSc serum treatment in comparison with their counterparts. TGF-beta 1 levels increased in cell culture supernatants of HDF cells exposed to TGF-beta 1 and SSc serum. An in vitro model of SSc serum-induced fibrosis using human HDF cells was evaluated in comparison to the TGF-beta 1 fibrosis induced model and data suggested that it may be used in documenting the role of pro-fibrotic factors in serum or plasma from SSc patients.Keywords
This publication has 40 references indexed in Scilit:
- Caffeic Acid Phenethyl Ester Inhibits Epithelial-Mesenchymal Transition of Human Pancreatic Cancer CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β–dependent mesenchymal‐to‐mesenchymal transitionArthritis & Rheumatism, 2012
- Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosisArthritis Research & Therapy, 2012
- An investigation of the inflammatory cytokine and chemokine network in systemic sclerosisAnnals of the Rheumatic Diseases, 2011
- Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cellsLaboratory Investigation, 2010
- Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the MouseThe Journal of Immunology, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- In vitro models of TGF-β-induced fibrosis suitable for high-throughput screening of antifibrotic agentsAmerican Journal of Physiology-Renal Physiology, 2007
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- A modified model of graft‐versus‐host–induced systemic sclerosis (scleroderma) exhibits all major aspects of the human diseaseArthritis & Rheumatism, 2004